This article was originally published in The Gray Sheet
Executive SummaryPrivately held maker of minimally invasive spinal surgery systems raises $29.3 mil. in an equity financing led by William Blair Capital Partners, firm reports May 21. Proceeds will be used to support the launch of the company's recently approved products, including the INS-1 intraoperative nerve surveillance system, which gained 510(k) clearance in November 2000 (1"The Gray Sheet" Dec. 11, 2000, p. 22). The San Diego company's other products include SpineArc surgical guide frame and the Vector cannulae for less traumatic access to the spine. Other investors included Sofinov and Kleiner Perkins Caulfield & Byers
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.